Winfried Kern to Germany
This is a "connection" page, showing publications Winfried Kern has written about Germany.
Connection Strength
0.467
-
[COVID-19-Response - Strategies of the Task-Force Coronavirus and experiences upon implementation in the management of 115 cases at the University Medical Center Freiburg]. Dtsch Med Wochenschr. 2020 05; 145(10):657-664.
Score: 0.069
-
[Rational prescription of antibiotics in human medicine]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 May; 61(5):580-588.
Score: 0.060
-
Antibiotic use in Germany and European comparison. Dtsch Med Wochenschr. 2004 Sep 17; 129(38):1987-92.
Score: 0.023
-
[Complaints and clinical findings six months after COVID-19: outpatient follow-up at the University Medical Center Freiburg]. Dtsch Med Wochenschr. 2021 Sep; 146(17):e65-e73.
Score: 0.019
-
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany. JAMA Pediatr. 2021 06 01; 175(6):586-593.
Score: 0.019
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
Score: 0.019
-
Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients. PLoS One. 2021; 16(5):e0249760.
Score: 0.019
-
Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19. Am J Hypertens. 2021 04 02; 34(3):278-281.
Score: 0.018
-
COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany. PLoS One. 2020; 15(11):e0242127.
Score: 0.018
-
Navigating hospitals safely through the COVID-19 epidemic tide: Predicting case load for adjusting bed capacity. Infect Control Hosp Epidemiol. 2021 Jun; 42(6):653-658.
Score: 0.018
-
Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany. Cancer Med. 2020 11; 9(22):8412-8422.
Score: 0.018
-
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):470.
Score: 0.017
-
Clinimetric properties and suitability of selected quality indicators for assessing antibiotic use in hospitalized adults: a multicentre point prevalence study in 24 hospitals in Germany. J Antimicrob Chemother. 2019 12 01; 74(12):3596-3602.
Score: 0.017
-
Phylogenetics of tick-borne encephalitis virus in endemic foci in the upper Rhine region in France and Germany. PLoS One. 2018; 13(10):e0204790.
Score: 0.016
-
Case Report and Genetic Sequence Analysis of Candidatus Borrelia kalaharica, Southern Africa. Emerg Infect Dis. 2018 09; 24(9):1659-1664.
Score: 0.015
-
Infectious disease services: a survey from four university hospitals in Germany. Infection. 2019 Feb; 47(1):27-33.
Score: 0.015
-
High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals. J Antimicrob Chemother. 2018 06 01; 73(6):1688-1691.
Score: 0.015
-
[Infectious diseases - a specialty of internal medicine]. Internist (Berl). 2018 Apr; 59(4):334-340.
Score: 0.015
-
Management of bloodstream infections by infection specialists in France and Germany: a cross-sectional survey. Infection. 2018 Jun; 46(3):333-339.
Score: 0.015
-
Five cases of vector-borne Francisella tularensis holarctica infections in south-western Germany and genetic diversity. Ticks Tick Borne Dis. 2017 08; 8(5):808-812.
Score: 0.014
-
Community-Associated Staphylococcus aureus from Sub-Saharan Africa and Germany: A Cross-Sectional Geographic Correlation Study. Sci Rep. 2017 03 13; 7(1):154.
Score: 0.014
-
The "Choosing Wisely" initiative in infectious diseases. Infection. 2017 Jun; 45(3):263-268.
Score: 0.014